Asthma, Chronic Obstructive Pulmonary Disease (COPD)
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
Analysis of the Virtual Acute Care at Home Experience
Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers
HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease